Pemanfaatan Artificial Intelligence (AI) dalam COVID-19 dan Diabetes Melitus: Narrative Review
DOI:
https://doi.org/10.54259/sehatrakyat.v5i4.9125Keywords:
Artificial Intelligence, COVID-19, Diabetes Mellitus, Machine Learning, Deep Learning, Narrative ReviewAbstract
Coronavirus Disease 2019 (COVID-19) in patients with diabetes mellitus is associated with a higher risk of complications and mortality than in the general population, highlighting the need for innovative approaches to support diagnosis, prognosis prediction, and patient management. This study aimed to summarize the current evidence on the application of artificial intelligence (AI) in the management of COVID-19 among patients with diabetes mellitus. A narrative review was conducted by searching the Scopus and PubMed databases for articles published between 2024 and 2026. Eligible studies were selected based on predefined inclusion and exclusion criteria and synthesized descriptively. The literature search identified 946 articles, including 850 from Scopus and 96 from PubMed. After removing 89 duplicate records and completing the screening process, 451 articles were included in the review. The findings indicate that AI has been widely applied in COVID-19 and diabetes management, including medical imaging-based diagnosis, disease severity and mortality prediction, glycemic management, telemedicine, drug discovery, and clinical decision support systems. The most frequently used AI algorithms were Convolutional Neural Network (CNN), Random Forest, Extreme Gradient Boosting (XGBoost), Support Vector Machine (SVM), and Artificial Neural Network (ANN). Overall, AI demonstrates considerable potential to improve diagnostic accuracy, healthcare efficiency, and clinical decision-making. However, broader validation, improved model interpretability, and greater attention to ethical and data security issues are required before widespread clinical implementation.
Downloads
References
Abdullah, M. Y., Alhaddad, F. A. K., Pambuk, C. I. A., & Marghali, S. (2025). Association of interleukin polymorphisms and inflammatory markers with hospitalization, survival, and COVID-19 severity in type 1 diabetes patients: A multivariate and Cox regression analysis. Cellular and Molecular Biology, 71(1). https://doi.org/10.14715/cmb/2025.70.1.14
Aishwarya, T., & Ravi Kumar, V. (2021). Machine Learning and Deep Learning Approaches to Analyze and Detect COVID-19: A Review. In SN Computer Science (Vol. 2, Number 3). https://doi.org/10.1007/s42979-021-00605-9
Alrubaie, M., Alkhaldi, M., Salvia, Z., Rasheed, F., & Lang, T. (2025). Rethinking global health research for better methods, processes, and capacity: global evidence and perspectives from the Global Health Network Conference 2022. In Global Health Journal (Vol. 9, Number 1). https://doi.org/10.1016/j.glohj.2025.02.001
Amiri, P., Montazeri, M., Ghasemian, F., Asadi, F., Niksaz, S., Sarafzadeh, F., & Khajouei, R. (2023). Prediction of mortality risk and duration of hospitalization of COVID-19 patients with chronic comorbidities based on machine learning algorithms. Digital Health, 9. https://doi.org/10.1177/20552076231170493
Booth G., McGlyn N., Fazli G., & et al. (2022). Diabetes and COVID-19: The role of glycaemic control, diabetes subtype and blood glucose on COVID-19 severity and death. Idf Atlas Reports.
Collins, G. S., Dhiman, P., Andaur Navarro, C. L., Ma, J., Hooft, L., Reitsma, J. B., Logullo, P., Beam, A. L., Peng, L., Van Calster, B., van Smeden, M., Riley, R. D., & Moons, K. G. M. (2021). Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open, 11(7). https://doi.org/10.1136/bmjopen-2020-048008
Davenport, T., & Kalakota, R. (2019). The potential for artificial intelligence in healthcare. Future Healthcare Journal, 6(2). https://doi.org/10.7861/futurehosp.6-2-94
El Sayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., Lingvay, I., Matfin, G., McCoy, R. G., Perry, M. Lou, Pilla, S. J., Polsky, S., Prahalad, P., Pratley, R. E., Segal, A. R., Seley, J. J., … Gabbay, R. A. (2024). Diabetes Technology: Standards of Care in Diabetes—2024. Diabetes Care, 47(Supplement_1), S126–S144. https://doi.org/10.2337/dc24-S007
Esteva, A., Robicquet, A., Ramsundar, B., Kuleshov, V., DePristo, M., Chou, K., Cui, C., Corrado, G., Thrun, S., & Dean, J. (2019). A guide to deep learning in healthcare. In Nature Medicine (Vol. 25, Number 1). https://doi.org/10.1038/s41591-018-0316-z
Guo, K., Zhi, H., Zhou, X., Huang, S., Lin, J., Pang, J., Xiao, L., Sun, W., & Zeng, C. (2025). Clinical outcomes and predictive modeling in COVID-19 patients with type 2 diabetes mellitus: a multicenter retrospective cohort study. BMC Infectious Diseases, 25(1). https://doi.org/10.1186/s12879-025-11578-y
International Diabetes Federation [IDF]. (2025). IDF Diabetes Atlas: Global Diabetes Data & Statistics. In Idf.
Isiaka, R. M., Babatunde, R. S., Ajao, J. F., Yusuff, S. R., Popoola, D. D., Arowolo, M. O., & Adewole, K. S. (2022). A Study of Impacts of Artificial Intelligence on COVID-19 Prediction, Diagnosis, Treatment, and Prognosis. Advances in Multidisciplinary and Scientific Research Journal Publication, 10. https://doi.org/10.22624/aims/maths/v10n4p2
Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019). Key challenges for delivering clinical impact with artificial intelligence. In BMC Medicine (Vol. 17, Number 1). https://doi.org/10.1186/s12916-019-1426-2
Kruse, C. S., Krowski, N., Rodriguez, B., Tran, L., Vela, J., & Brooks, M. (2017). Telehealth and patient satisfaction: A systematic review and narrative analysis. In BMJ Open (Vol. 7, Number 8). https://doi.org/10.1136/bmjopen-2017-016242
Labrique, A. B., Vasudevan, L., Kochi, E., Fabricant, R., & Mehl, G. (2013). Mhealth innovations as health system strengthening tools: 12 common applications and a visual framework. Global Health Science and Practice, 1(2). https://doi.org/10.9745/GHSP-D-13-00031
Leslie, D. (2020). Understanding Artificial Intelligence Ethics and Safety: A Guide for the Responsible Design and Implementation of AI Systems in the Public Sector. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3403301
Mak, K. K., & Pichika, M. R. (2019). Artificial intelligence in drug development: present status and future prospects. In Drug Discovery Today (Vol. 24, Number 3). https://doi.org/10.1016/j.drudis.2018.11.014
Meints, S. M., & Edwards, R. R. (2018). Evaluating psychosocial contributions to chronic pain outcomes. In Progress in Neuro-Psychopharmacology and Biological Psychiatry (Vol. 87). https://doi.org/10.1016/j.pnpbp.2018.01.017
Mohammad talebi, H., Safarabadi, M., Mousivand, M., Zarei, A., & Fakhari, M. S. (2025). Role of artificial intelligence powered chatbots in diabetes self-management: A narrative review. In Proceedings of Singapore Healthcare (Vol. 34). https://doi.org/10.1177/20101058251389342
Monaghesh, E., & Hajizadeh, A. (2020). The role of telehealth during COVID-19 outbreak: a systematic review based on current evidence. BMC Public Health, 20(1), 1193. https://doi.org/10.1186/s12889-020-09301-4
Morley, J., Machado, C. C. V., Burr, C., Cowls, J., Joshi, I., Taddeo, M., & Floridi, L. (2020). The ethics of AI in health care: A mapping review. Social Science & Medicine, 260, 113172. https://doi.org/10.1016/j.socscimed.2020.113172
Mundt, C., Yusufoğlu, B., Kudenko, D., Mertoğlu, K., & Esatbeyoglu, T. (2025). AI-Driven Personalized Nutrition: Integrating Omics, Ethics, and Digital Health. In Molecular Nutrition and Food Research (Vol. 69, Number 24). https://doi.org/10.1002/mnfr.70293
Natrayan, L., Kamal, M. D. R., Manivannan, K. K., & Sunil, G. (2024). Machine Learning and Data Mining Approaches for Infectious Disease Surveillance and Outbreak Management in Healthcare. 2024 International Conference on Advancements in Smart, Secure and Intelligent Computing (ASSIC), 1–7. https://doi.org/10.1109/ASSIC60049.2024.10507990
Nivethitha, V., Daniel, R. A., Surya, B. N., & Logeswari, G. (2025). Empowering public health: Leveraging AI for early detection, treatment, and disease prevention in communities - A scoping review. In Journal of Postgraduate Medicine (Vol. 71, Number 2). https://doi.org/10.4103/jpgm.jpgm_634_24
Rahmadina, N., Linawati, S. W., Khairunnisa, S. H. H., Basrowi, R. W., & Riadi, D. (2026). A Systematic Literature Review of Husband’s Support for the Incidence of Postpartum Depression in Indonesia. The Open Public Health Journal, 19(1). https://doi.org/10.2174/0118749445424980260202101630
Rajpurkar, P., Chen, E., Banerjee, O., & Topol, E. J. (2022). AI in health and medicine. In Nature Medicine (Vol. 28, Number 1). https://doi.org/10.1038/s41591-021-01614-0
Riadi, D., & Sari, D. N. (2026). DATA MINING UNTUK PENGAMBILAN KEPUTUSAN DAN KEBIJAKAN KESEHATAN MASYARAKAT: NARRATIVE REVIEW. Rabit : Jurnal Teknologi Dan Sistem Informasi Univrab, 11(2), 4175–4185. https://doi.org/10.36341/rabit.v11i2.8251
Riadi, D., Trihandini, I., Sari, D. N., & Wijaya, F. (2025). The Effectiveness of Remote Patient Monitoring in Reducing the Risk of Rehospitalizations in COVID-19 Patients: A Meta-Analysis. Kesmas: Jurnal Kesehatan Masyarakat Nasional, 20(5). https://doi.org/10.7454/kesmas.v20isp1.1715
Salari, M., Sadati, S. M., Sedaghat, A., Abbasi, B., Zamanpour, S. A., Khodashahi, R., & Davoudi, M. (2025). Evaluating the Application of Machine Learning in Predicting the Mortality of Hospitalized COVID-19 Patients Using the Confusion Matrix and the Matthews Correlation Coefficient. Archives of Clinical Infectious Diseases, 20(2). https://doi.org/10.5812/archcid-150150
Seyyed-Kalantari, L., Zhang, H., McDermott, M. B. A., Chen, I. Y., & Ghassemi, M. (2021). Underdiagnosis bias of artificial intelligence algorithms applied to chest radiographs in under-served patient populations. Nature Medicine, 27(12). https://doi.org/10.1038/s41591-021-01595-0
Shen, J., Wang, Y., Deng, X., & Sana, S. R. G. L. (2023). Combining bioinformatics and machine learning algorithms to identify and analyze shared biomarkers and pathways in COVID-19 convalescence and diabetes mellitus. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1306325
Sperl-Hillen, J. A. M., Haapala, J. L., Dehmer, S. P., Chumba, L. N., Ekstrom, H. L., Truitt, A. R., Asche, S. E., Werner, A. M., Rehrauer, D. J., Pankonin, M. A., Pawloski, P. A., & O’Connor, P. J. (2024). Protocol of a patient randomized clinical trial to improve medication adherence in primary care. Contemporary Clinical Trials, 136. https://doi.org/10.1016/j.cct.2023.107385
Talha, S., Lamrous, S., Kassegne, L., Lefebvre, N., Zulfiqar, A. A., Tran Ba Loc, P., Geny, M., Meyer, N., Hajjam, M., Andrès, E., & Geny, B. (2023). Early Hospital Discharge Using Remote Monitoring for Patients Hospitalized for COVID-19, Regardless of Need for Home Oxygen Therapy: A Descriptive Study. Journal of Clinical Medicine, 12(15). https://doi.org/10.3390/jcm12155100
Topol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. In Nature Medicine (Vol. 25, Number 1). https://doi.org/10.1038/s41591-018-0300-7
Vamathevan, J., Clark, D., Czodrowski, P., Dunham, I., Ferran, E., Lee, G., Li, B., Madabhushi, A., Shah, P., Spitzer, M., & Zhao, S. (2019). Applications of machine learning in drug discovery and development. In Nature Reviews Drug Discovery (Vol. 18, Number 6). https://doi.org/10.1038/s41573-019-0024-5
Wang, T., Song, H., Wang, Q., Hou, Y., Liu, H., & Zhang, L. (2024). Brief introduction and inspiration to the WHO guidance on Ethics and Governance of Artificial Intelligence for Health. Chinese Journal of Pharmacovigilance, 21(8). https://doi.org/10.19803/j.1672-8629.20230518
WHO Media Team. (2024). WHO releases AI ethics and governance guidance for large multi-modal models. WHO.Int.Com.
WHO Team. (2021). Global Strategy on Digital Health 2020-2025. World Health Organization, 12(1).
Wouters, O. J., Shadlen, K. C., Salcher-Konrad, M., Pollard, A. J., Larson, H. J., Teerawattananon, Y., & Jit, M. (2021). Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. In The Lancet (Vol. 397, Number 10278). https://doi.org/10.1016/S0140-6736(21)00306-8
Wynants, L., Van Calster, B., Collins, G. S., Riley, R. D., Heinze, G., Schuit, E., Albu, E., Arshi, B., Bellou, V., Bonten, M. M. J., Dahly, D. L., Damen, J. A., Debray, T. P. A., de Jong, V. M. T., De Vos, M., Dhiman, P., Ensor, J., Gao, S., Haller, M. C., … van Smeden, M. (2020). Prediction models for diagnosis and prognosis of covid-19: Systematic review and critical appraisal. BMJ, 369. https://doi.org/10.1136/bmj.m1328
Zaslavsky, M. E., Craig, E., Michuda, J. K., Sehgal, N., Ram-Mohan, N., Lee, J. Y., Nguyen, K. D., Hoh, R. A., Pham, T. D., Röltgen, K., Lam, B., Parsons, E. S., Macwana, S. R., DeJager, W., Drapeau, E. M., Roskin, K. M., Cunningham-Rundles, C., Anthony Moody, M., Haynes, B. F., … Boyd, S. D. (2025). Disease diagnostics using machine learning of B cell and T cell receptor sequences. Science, 387(6736). https://doi.org/10.1126/science.adp2407
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dela Riadi, Siti Nuriyatus Zahrah, Fajar Edyana

This work is licensed under a Creative Commons Attribution 4.0 International License.
Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa SEHATRAKYAT (Jurnal Kesehatan Masyarakat) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada SEHATRAKYAT (Jurnal Kesehatan Masyarakat).









